United Services Automobile Association Ionis Pharmaceuticals Inc Transaction History

United Services Automobile Association

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$59.06 - $72.15 $1.46 Million - $1.78 Million	-24,703 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$62.09 - $86.14 $160,440 - $222,585	2,584 Added 11.68%	24,703 $1.59 Million
Q1 2019 May 13, 2019	SELL	$52.92 - $81.17 $165,745 - $254,224	-3,132 Reduced 12.4%	22,119 $1.8 Million
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $212,727 - $266,405	4,961 Added 24.45%	25,251 $1.3 Million
Q2 2018 Sep 27, 2018	BUY	$40.53 - $50.7 $270,254 - $338,067	6,668 Added 48.95%	20,290 $845,000
Q2 2018 Aug 10, 2018	SELL	$40.53 - $50.7 $224,657 - $281,030	-5,543 Reduced 28.92%	13,622 $140,000
Q1 2018 May 14, 2018	BUY	$44.08 - $55.05 $844,793 - $1.06 Million	19,165 New	19,165 $845,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.